Integra HR chief disposes 1,455 shares at $16.62
Integra LifeSciences’ EVP & CHRO had 1,455 IART shares withheld for tax or exercise costs, leaving her with 20,772 directly held shares.
Rhea-AI Filing Summary
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported that executive vice president and chief human resources officer Chantal Veillon-Berteloot had 1,455 shares of Common Stock disposed of on September 1, 2026 as a payment of exercise price or tax liability by delivering or withholding securities. The shares were treated as a non-derivative transaction at a reported price of $16.62 per share, and she now holds 20,772 shares directly. No Rule 10b5-1 trading plan is indicated for this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise Price or Tax Liability: 1,455 shares
Exercise Price or Tax Liability
1 txn
Insider
Veillon-Berteloot Chantal
Role
EVP & CHRO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 1,455 | $16.62 | $24K |
Holdings After Transaction:
Common Stock — 20,772 shares (Direct)
Key Figures
Shares disposed for exercise price or tax liability: 1,455 shares
Reported transaction price per share: $16.62 per share
Shares held after transaction: 20,772 shares
+1 more
4 metrics
Shares disposed for exercise price or tax liability
1,455 shares
Non-derivative Common Stock transaction on September 1, 2026
Reported transaction price per share
$16.62 per share
Code F disposition used to pay exercise price or tax liability
Shares held after transaction
20,772 shares
Directly held Common Stock following the September 1, 2026 transaction
Exercise price or tax liability shares in this filing
1,455 shares
Total shares reported under code F in the transaction summary
Key Terms
Common Stock, Payment of exercise price or tax liability by delivering or withholding securities, Rule 10b5-1
3 terms
Common Stock financial
"security title reported as Common Stock in the non-derivative transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Payment of exercise price or tax liability by delivering or withholding securities financial
"transaction described as Payment of exercise price or tax liability by delivering"
Rule 10b5-1 regulatory
"Rule 10b5-1 trading plan status is shown by the document-level checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What insider transaction did IART disclose for Chantal Veillon-Berteloot?
Integra LifeSciences disclosed that EVP & CHRO Chantal Veillon-Berteloot had 1,455 shares of Common Stock disposed of on September 1, 2026 to cover exercise price or tax liability by delivering or withholding securities.
Was the September 1, 2026 IART insider transaction under a Rule 10b5-1 plan?
No. The Form 4 data shows the Rule 10b5-1 checkbox as not affirmed, indicating the September 1, 2026 transaction was not reported as being made under a Rule 10b5-1 trading plan.
What type of Form 4 code applies to the recent IART insider transaction?
The transaction is coded as F, which represents payment of exercise price or tax liability by delivering or withholding securities for Common Stock, rather than an open market purchase or sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
